Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2011 Mar;22(3):545-53. doi: 10.1681/ASN.2010040354. Epub 2011 Feb 25.

2.

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop PH; FinnDiane Study Group..

J Am Soc Nephrol. 2011 Mar;22(3):537-44. doi: 10.1681/ASN.2010020194. Epub 2011 Feb 18.

3.

Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.

Costacou T, Fried L, Ellis D, Orchard TJ.

Am J Kidney Dis. 2011 Oct;58(4):565-73. doi: 10.1053/j.ajkd.2011.05.025. Epub 2011 Aug 15.

4.

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51. doi: 10.2215/CJN.00580111. Epub 2011 Aug 18.

5.

Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group..

J Am Soc Nephrol. 2014 Oct;25(10):2342-50. doi: 10.1681/ASN.2013091004. Epub 2014 Jun 12.

6.

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes.

Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, Knowler WC, Nelson RG.

Diabetes Care. 2007 Feb;30(2):306-11.

PMID:
17259499
7.

Haptoglobin genotype and renal function decline in type 1 diabetes.

Costacou T, Ferrell RE, Ellis D, Orchard TJ.

Diabetes. 2009 Dec;58(12):2904-9. doi: 10.2337/db09-0874. Epub 2009 Aug 31.

8.

[REIN Report 2011--summary].

Couchoud C, Lassalle M, Jacquelinet C.

Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1. French.

PMID:
24119584
9.

Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.

Costacou T, Ellis D, Fried L, Orchard TJ.

Am J Kidney Dis. 2007 Nov;50(5):721-32.

PMID:
17954285
10.

Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?

Tan J, Jaung R, Gamble G, Cundy T.

Diabetes Res Clin Pract. 2014 Jan;103(1):63-70. doi: 10.1016/j.diabres.2013.11.023. Epub 2013 Dec 6.

PMID:
24380605
11.

Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG.

JAMA. 2006 Jul 26;296(4):421-6.

PMID:
16868300
12.

Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.

Bentata Y, Haddiya I, Latrech H, Serraj K, Abouqal R.

Saudi J Kidney Dis Transpl. 2013 Mar;24(2):392-402.

13.
14.

Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Parving HH.

Diabetologia. 2005 Nov;48(11):2241-7. Epub 2005 Sep 17.

PMID:
16170513
15.

Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry.

Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ; Diabetes Epidemiology Research International Mortality Study.; Allegheny County Registry..

Am J Kidney Dis. 2003 Jul;42(1):117-24.

PMID:
12830463
16.

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group..

Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17.

PMID:
18346990
17.

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.

Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.

Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.

PMID:
22051245
18.

Differences in survival between black and white patients with diabetic end-stage renal disease.

Cowie CC, Port FK, Rust KF, Harris MI.

Diabetes Care. 1994 Jul;17(7):681-7.

PMID:
7924777
19.

Incidence of end-stage renal disease in patients with type 1 diabetes.

Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C.

JAMA. 2005 Oct 12;294(14):1782-7.

PMID:
16219881
20.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19.

Supplemental Content

Support Center